3 US Penny Stocks With Market Caps Under $200M To Watch

Major U.S. stock indexes are poised to open higher after a turbulent week, with investors closely monitoring economic data and earnings reports. For those willing to explore beyond the well-known names, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities. While the term might seem outdated, these stocks continue to present potential for growth at lower price points when backed by strong financials.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
BAB (OTCPK:BABB)	$0.7553	$5.71M	★★★★★★
LexinFintech Holdings (NasdaqGS:LX)	$3.15	$526.12M	★★★★★★
RLX Technology (NYSE:RLX)	$1.60	$2.03B	★★★★★★
ARC Document Solutions (NYSE:ARC)	$3.43	$147.91M	★★★★★★
Permianville Royalty Trust (NYSE:PVL)	$1.58	$53.13M	★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U)	$4.50	$69.71M	★★★★★★
Imperial Petroleum (NasdaqCM:IMPP)	$3.68	$112.23M	★★★★★★
MIND C.T.I (NasdaqGM:MNDO)	$1.88	$39.99M	★★★★★★
Zynerba Pharmaceuticals (NasdaqCM:ZYNE)	$1.30	$65.6M	★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)	$1.05	$96.23M	★★★★★☆

Click here to see the full list of 760 stocks from our US Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Intellicheck (NasdaqGM:IDN)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Intellicheck, Inc. is a technology company offering digital identity validation solutions for KYC, fraud prevention, and age verification in North America with a market cap of $44.73 million.

Operations: The company generates revenue from its Electronic Security Devices segment, amounting to $19.29 million.

Market Cap: $44.73M

Intellicheck, Inc., with a market cap of US$44.73 million, has shown resilience in its financial performance despite being unprofitable. Recent earnings reports indicate a reduction in net losses, reflecting an improvement over the past year. The company reported sales of US$4.67 million for Q2 2024 and has managed to maintain a stable cash runway for over three years without incurring debt. However, the stock remains highly volatile and is trading significantly below estimated fair value. The appointment of Adam Sragovicz as CFO may bring strategic financial oversight to support future growth initiatives.

• Click here and access our complete financial health analysis report to understand the dynamics of Intellicheck.
• Examine Intellicheck's earnings growth report to understand how analysts expect it to perform.

So-Young International (NasdaqGM:SY)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: So-Young International Inc. operates an online platform for consumption healthcare services in the People’s Republic of China, with a market cap of $101.50 million.

Operations: The company's revenue segment is entirely derived from China, amounting to CN¥1.50 billion.

Market Cap: $101.5M

So-Young International Inc., with a market cap of US$101.50 million, has demonstrated significant earnings growth of 75.8% over the past year, surpassing industry averages. The company's revenue for the second quarter was CN¥407.38 million, with a net income turnaround from a loss to CN¥18.94 million compared to last year. Despite its high volatility and recent shareholder dilution, So-Young maintains strong financial health with more cash than debt and short-term assets exceeding liabilities significantly. However, its return on equity remains low at 1.5%, and management tenure is relatively short but experienced at 2.1 years on average.

• Unlock comprehensive insights into our analysis of So-Young International stock in this financial health report.
• Evaluate So-Young International's prospects by accessing our earnings growth report.

Zevia PBC (NYSE:ZVIA)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Zevia PBC is a beverage company that develops, markets, sells, and distributes various carbonated beverages in the United States and Canada, with a market cap of $79.26 million.

Operations: The company generates $160.11 million in revenue from its non-alcoholic beverage segment.

Market Cap: $79.26M

Zevia PBC, with a market cap of US$79.26 million, operates in the non-alcoholic beverage sector generating US$160.11 million in revenue. Despite being debt-free and having sufficient cash runway for over a year, Zevia faces challenges with profitability as it remains unprofitable with increasing losses over the past five years. The company's recent board changes and product launches like Salted Caramel Soda aim to capture consumer interest amidst high share price volatility and its removal from the S&P Global BMI Index. Short-term assets comfortably cover liabilities, but management's short tenure highlights potential leadership instability.

• Jump into the full analysis health report here for a deeper understanding of Zevia PBC.
• Review our growth performance report to gain insights into Zevia PBC's future.

Where To Now?

• Access the full spectrum of 760 US Penny Stocks by clicking on this link.
• Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com